on outsourced networks. A final validation of this tenet comes from the large CROs themselves, which, in order to offer the one-stop shop from which they can benefit substantially as a provider, often resort themselves to sub-contracting. It will be interesting to see how this trend develops in the next few years, in an age when the business of pharmaceutical development is still growing, becoming ever more international in scope, more competitive and more complex.
越来越多的人意识到专业化公司可以为外包带来价值，同时人们把中间公司的角色看作服务于以研究为基础的制药部门。事实上我们不应该感到惊讶，“企业家”一词已意味着“to take between”，在所有的工业产业中，当他们变得成熟完整，公司经常会变得更加专业与他们的服务，机会也为更多的商业中介打开。在这里列举一个很有效的比较，电脑制造业被分成无数个部分，依赖于外部资源的网络。这种原则的最终确立来自于大型CRO，他们通过提供阶段性的服务，获得稳定的充足的收入，而凭借于缩小。，将很有意思看到这种变化趋势。
Outsourcing is no doubt a trend that will increase and, in order to improve its efficiency, the ways in which it is managed are likely to see dramatic change.
外包毫无疑问是一种趋势，为提高效率，管理将会发生戏剧性的改变。
How will the emergence of specialist intermediary organization affect the process? 专业型中间公司的出现将如何影响进程？ By David Cavalla MA PHD Arachnova
摘自 www.contractpharm.com/Oct011.htm
9
